Skip to main content
. 2020 Jan 28;11(2):547–563. doi: 10.1002/jcsm.12527

Figure 1.

Figure 1

Schematic diagrams resuming findings obtained from (A) 2D‐DIGE and (B) label‐free LC‐MS/MS proteomic analyses. 2D‐DIGE, two‐dimensional difference in gel electrophoresis; BMD, Becker muscular dystrophy; DMD, Duchenne muscular dystrophy; LC‐MS/MS, liquid chromatography with tandem mass spectrometry.